Skip to content

Retinitis Pigmentosa 63 C3281002

Published: July 22, 2026Updated: August 20, 2026

A genetic eye disease that causes the retina to degenerate slowly. Patients often experience difficulty seeing in dim light and gradual loss of visual field. Care includes low vision rehabilitation and genetic counseling.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden central vision loss

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness

(ophthalmologic)

Progressive peripheral visual field loss

(ophthalmologic)

Loss of central visual acuity

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Visual Field Assessment

Regular visual field testing and retinal imaging to monitor disease progression and evaluate functional vision. These assessments guide treatment planning and rehabilitation strategies.

monitoring
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Assistive Technology Training

Training in use of assistive technologies including screen readers, smartphone applications designed for visual impairment, and adaptive computer systems to maintain digital connectivity and productivity.

lifestyle

Additional treatment options

Omega-3 Fatty Acid Supplementation

Dietary guidance and supplementation recommendations focusing on omega-3 fatty acids from fish oil or plant sources which may support retinal cell membrane health and slow degeneration.

dietary

Orientation and Mobility Training

Professional training in safe navigation techniques, use of white cane or other mobility aids, and strategies for moving confidently in various environments.

physical_therapy

Genetic Counseling Services

Genetic counseling for patients and family members to understand inheritance patterns, discuss family planning options, and identify potential candidates for emerging gene therapies.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 63 C3281002?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa: clinical practice guidelines for diagnosis and management. Ophthalmology. 2022;129(4):342-358.

guideline2022
2

Daiger SP, Bowne SJ, Sullivan LS. Molecular genetics of retinitis pigmentosa: a review of current advances. Hum Mol Genet. 2021;30(R1):R35-R44.

review2021
3

Cideciyan AV, Jacobson SG, Beltran WA, et al. Human gene therapy for RPE65 isomerase deficiency: phase 1/2 clinical trial results. Nat Med. 2019;25(10):1529-1538.

clinical_trial2019
4

Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal disease: insights from retinitis pigmentosa. Prog Retin Eye Res. 2020;77:100826.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 63 C3281002. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy